BRIEF published on 07/20/2026 at 17:50, 1 month 22 days ago EMS Group: Revenue Decline in Q2 2026 Revenue International Market Radiology Bone Densitometry EMS Group
BRIEF published on 07/20/2026 at 17:50, 1 month 22 days ago EMS Group : Recul du Chiffre d'Affaires au 2ème Trimestre 2026 Chiffre D'affaires Marché International Radiologie Ostéodensitométrie EMS Group
PRESS RELEASE published on 07/20/2026 at 17:45, 1 month 22 days ago CHIFFRE D'AFFAIRES DU 2ÈME TRIMESTRE 2026 : 12,1 M EUR EMS Group annonce un chiffre d'affaires consolidé en repli de -4% au 2ème trimestre 2026 par rapport à 2025. Perspectives de croissance malgré les défis. Informations financières disponibles Chiffre D'affaires Croissance Perspectives Imagerie Médicale EMS Group
BRIEF published on 04/14/2026 at 17:50, 4 months 27 days ago EMS Group: 2025 Annual Results on the Rise EBITDA Growth Radiology 2025 Results EMS Group
BRIEF published on 04/14/2026 at 17:50, 4 months 27 days ago EMS Group : Résultats annuels 2025 en hausse Croissance EBITDA Radiologie Résultats 2025 EMS Group
PRESS RELEASE published on 04/14/2026 at 17:45, 4 months 27 days ago RÉSULTATS ANNUELS 2025 EMS Group publie ses résultats annuels 2025 avec une croissance de +11% du chiffre d'affaires, une progression de +23% de l'EBITDA et une amélioration de +1,3 M€ du résultat net. Perspectives de croissance pour 2026 malgré des défis sectoriels Croissance EBITDA Résultats Annuels EMS Group Perspectives 2026
BRIEF published on 01/19/2026 at 17:50, 7 months 23 days ago EMS Group: Organic Growth of 11% in 2025 Organic Growth International Expansion Radiology Bone Densitometry EMS Group
BRIEF published on 01/19/2026 at 17:50, 7 months 23 days ago EMS Group : Croissance Organique de 11 % en 2025 Croissance Organique Expansion Internationale Radiologie Ostéodensitométrie EMS Group
PRESS RELEASE published on 01/19/2026 at 17:45, 7 months 23 days ago 50 M EUR DE CHIFFRE D'AFFAIRES ANNUEL 2025 EN CROISSANCE ORGANIQUE DE +11% EMS Group annonce une croissance de +15% au 4ème trimestre 2025, tirée par le développement international. Accélération confirmée de la croissance au 2nd semestre 2025. Forte progression aux USA Croissance Développement International USA EMS Group 4ème Trimestre 2025
BRIEF published on 10/20/2025 at 17:50, 10 months 22 days ago EMS Group : Croissance de 10% au 3ème Trimestre 2025 Chiffre D'affaires Croissance International Radiologie EMS Group
Published on 09/12/2026 at 02:35, 11 hours 6 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 41 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 36 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 16 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 41 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 10 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 26 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 30 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 56 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 25 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
